Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 141,922 shares at $15.90 ($2.3M) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Scheduled sale ($2.3M) by Executive VP, European Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.90 | 48,385 | $769K | 34.1% |
| 2 | $15.90 | 48,385 | $769K | 34.1% |
| 3 | $15.91 | 22,576 | $359K | 15.9% |
| 4 | $15.91 | 22,576 | $359K | 15.9% |
| Total | $15.90 avg | 141,922 | $2.3M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |